Bcl-w Inhibitor, Navitoclax, Enhances the Activity of Chemotherapeutic Agents In Vitro and In Vivo

Overview of attention for article published in Molecular Cancer Therapeutics, December 2011

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (92nd percentile)
High Attention Score compared to outputs of the same age and source (93rd percentile)

Mentioned by

blogs: 1 blog
patent: 18 patents

wikipedia: 1 Wikipedia page

Citations

dimensions_citation: 130 Dimensions

Readers on

mendeley: 123 Mendeley

So far, Altmetric has seen 18 patents that reference this research output.

American Association for Cancer Research

Article Metrics

The Bcl-2/Bcl-XL/Bcl-w Inhibitor, Navitoclax, Enhances the Activity of Chemotherapeutic Agents In Vitro and In Vivo

About this Attention Score

Mentioned by

Citations

Readers on

Anti-EGFR antibody-drug conjugates

Grant US-11759527-B2

United States of America

Cytotoxic and anti-mitotic compounds, and methods of using the same

Grant US-11617777-B2

United States of America

Cytotoxic and anti-mitotic compounds, and methods of using the same

Grant US-11591405-B2

United States of America

Sulfonamide-containing linkage systems for drug conjugates

Grant US-11560422-B2

United States of America

Synergistic antitumor effect of Bcl-2 inhibitor combined with rituximab and/or…

Grant US-11554127-B2

United States of America

Combination product of Bcl-2 inhibitor and chemotherapeutic agent and use thereof in the…

Grant US-11491167-B2

United States of America

Combination product of BCL-2 inhibitor and MDM2 inhibitor and use thereof in the…

Grant US-11478469-B2

United States of America

Combination product of Bcl-2 inhibitor or Bcl-2/Bcl-xL dual inhibitor and BTK inhibitor…

Grant US-11478470-B2

United States of America

Compounds that induce degradation of anti-apoptotic Bcl-2 family proteins and the uses…

Grant US-11319316-B2

United States of America

MEDICAL USES, METHODS AND USES

Application WO-2020245160-A1

World Intellectual Property Organisation (WIPO)

Compounds that induce degradation of anti-apoptotic Bcl-2 family proteins and the uses…

Grant US-10807977-B2

United States of America

Compositions and methods for selectively depleting senescent cells

Grant US-10758524-B2

United States of America

VAR2CSA-drug conjugates

Grant US-10675355-B2

United States of America

Cytotoxic and anti-mitotic compounds, and methods of using the same

Grant US-10450378-B2

United States of America

Cytotoxic and anti-mitotic compounds, and methods of using the same

Grant US-10414822-B2

United States of America

Cytotoxic and anti-mitotic compounds, and methods of using the same

Grant US-10201614-B2

United States of America

Cytotoxic and anti-mitotic compounds, and methods of using the same

Grant US-9879086-B2

United States of America

Cytotoxic and anti-mitotic compounds, and methods of using the same

Grant US-9522876-B2

United States of America